These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 8977757)

  • 1. The effect of sequential administration of octreotide alone and octreotide/growth hormone simultaneously on buserelin stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
    Piaditis GP; Hatziioanidis AH; Trovas GP; Misichronis GS; Kounadi TG; Devetzaki OA; Andronis CK; Rangou DB; Chlouverakis CS
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):595-604. PubMed ID: 8977757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.
    Patel K; Coffler MS; Dahan MH; Malcom PJ; Deutsch R; Chang RJ
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):67-74. PubMed ID: 14678290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome.
    Prelević GM; Wurzburger MI; Balint-Perić L; Nesić JS
    Lancet; 1990 Oct; 336(8720):900-3. PubMed ID: 1976930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome.
    Wu X; Sallinen K; Zhou S; Su Y; Pöllänen P; Erkkola R
    Fertil Steril; 2000 Apr; 73(4):730-4. PubMed ID: 10731533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
    Unlühizarci K; Keleştimur F; Bayram F; Sahin Y; Tutuş A
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):231-6. PubMed ID: 10468995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
    White D; Leigh A; Wilson C; Donaldson A; Franks S
    Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide effect on ovarian morphology in insulin-resistant PCOS patients following six-month decapeptyl treatment.
    Goni MH; Markussis V; Tolis G
    Am J Reprod Immunol; 1994; 31(2-3):104-11. PubMed ID: 8049019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian function in women with non-insulin dependent diabetes mellitus.
    Stamataki KE; Spina J; Rangou DB; Chlouverakis CS; Piaditis GP
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):615-21. PubMed ID: 8977760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease.
    Fulghesu AM; Lanzone A; Andreani CL; Pierro E; Caruso A; Mancuso S
    Fertil Steril; 1995 Oct; 64(4):703-8. PubMed ID: 7672138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the sensitivity of serum insulin-like growth factor 1 and insulin-like growth factor binding protein-3 to octreotide in polycystic ovary syndrome.
    Morris RS; Carmina E; Vijod MA; Stanczyk FZ; Lobo RA
    Fertil Steril; 1995 Apr; 63(4):742-6. PubMed ID: 7534239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LH pulsatility and response to a single s.c. injection of buserelin in polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Balint-Peric L
    Gynecol Endocrinol; 1990 Mar; 4(1):1-13. PubMed ID: 2110712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.
    Lanzone A; Fulghesu AM; Andreani CL; Apa R; Fortini A; Caruso A; Mancuso S
    Hum Reprod; 1990 Feb; 5(2):143-9. PubMed ID: 2108986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
    Tosi F; Negri C; Perrone F; Dorizzi R; Castello R; Bonora E; Moghetti P
    J Clin Endocrinol Metab; 2012 May; 97(5):1712-9. PubMed ID: 22419715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the somatostatin analogue, octreotide, in polycystic ovary syndrome.
    Prelević GM; Wurzburger MI; Balint-Perić L; Hardiman P; Okolo S; Maletić D; Ginsburg J
    Metabolism; 1992 Sep; 41(9 Suppl 2):76-9. PubMed ID: 1518438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunction of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovarian syndrome.
    Piaditis GP; Kounadi TG; Rangou DB; Trovas GP; Kaklas NA; Tzonou AJ; Chlouverakis CS
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):635-40. PubMed ID: 7634505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia.
    Ciotta L; De Leo V; Galvani F; La Marca A; Cianci A
    Hum Reprod; 1999 Dec; 14(12):2951-8. PubMed ID: 10601077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
    Ruchhoft EA; Elkind-Hirsch KE; Malinak R
    Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome.
    Moran C; Renteria JL; Moran S; Herrera J; Gonzalez S; Bermudez JA
    Fertil Steril; 2008 Dec; 90(6):2310-7. PubMed ID: 18163993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.